New mRNA Vaccine Trains the Immune System to Attack Cancer Cells Scientists have developed a new experimental mRNA-based cancer vaccine designed to train the immune system to recognize and attack tumor cells. Instead of targeting one cancer type, the vaccine helps the body identify cancer-specific markers. The approach has shown strong tumor-fighting responses in early studies, but it is not yet a universal cure and remains under clinical research. Important Details: • Based on mRNA vaccine tech